SPL Initiative, Interagency Website Offer Easy Access to Drug Data, FDA Says

Drug Industry Daily
KEYWORDS FDA / Technology

The FDA Nov. 2 began requiring drug manufacturers to submit certain prescription human drug label information in the structured product labeling (SPL) format to make the data in agency-approved package inserts more accessible to healthcare providers and consumers.

To View This Article:


Subscribe To Drug Industry Daily